ACE inhibitors and chronotherapy

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Chronobiology

Background:

• Chronotherapy optimizes drug efficacy and minimizes adverse reactions.
• Angiotensin converting enzyme (ACE) inhibitors are crucial for hypertension and heart failure but cause side effects like angioedema and dry cough.
• Timing of medication administration can significantly impact therapeutic outcomes.

Purpose of the Study:

• To evaluate the impact of dosing time on the efficacy and safety of angiotensin converting enzyme (ACE) inhibitors.
• To explore the potential of chronotherapy in managing hypertension and reducing ACE inhibitor-induced side effects.

Main Methods:

• Review of existing literature on chronotherapy with ACE inhibitors.
• Analysis of studies investigating the effects of morning versus evening dosing on cardiovascular parameters and adverse events.
• Examination of preclinical data on ACE inhibitor administration during inactive periods in hypertensive models.

Main Results:

• Dosing ACE inhibitors during a patient's inactive period demonstrates enhanced protective effects against cardiac hypertrophy in hypertensive rats.
• Administering ACE inhibitors in the evening has been shown to decrease the severity and frequency of dry cough in hypertensive patients compared to morning dosing.
• Optimizing ACE inhibitor administration time can lead to improved therapeutic benefits and reduced side effect burden.

Conclusions:

• Administering ACE inhibitors during the inactive phase is more effective and safer for patients.
• Evening dosing of ACE inhibitors presents a viable alternative for hypertensive individuals experiencing dry cough with morning regimens.
• Further investigation is warranted to ensure evening dosing does not induce circadian hyperamplitude tension.